Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
about
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Optimal chemotherapy for leukemia: a model-based strategy for individualized treatment.Review article: monitoring of immunomodulators in inflammatory bowel disease.Megaloblastic anemia and other causes of macrocytosisChange in hematologic indices over time in pediatric inflammatory bowel disease treated with azathioprineAllopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease.Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration.Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis.6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.Azathioprine-induced suicidal erythrocyte death.Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.Thiopurine Metabolism in the Era of Combotherapy.
P2860
Q26777409-EB4DA3A0-F5A7-480C-B843-705DCF25BE64Q35327001-1F42069C-C7EB-438E-B62B-F98429BF9BF2Q36041146-323E33AA-5433-4B2B-A69A-DCE886AF8378Q36599359-5E9CAA32-998A-4505-BE3D-0DB96FF5D33EQ36650158-611D8E9F-A54C-4B03-949C-5EC146F37067Q38179509-20BA0687-9EF1-47ED-864B-9862E0F1563AQ40478934-DD65A6F7-3466-41FE-A179-8040B4F3122AQ40524189-A6655ECD-2CF7-4F6E-A579-09AA299BF9CEQ43159235-A1515A0C-9DF0-455D-80CD-BBB24D10DB40Q43532191-1F385779-85DD-4562-B457-94ABFF783623Q44963255-216EEBD4-4B2D-4C1D-A7FB-5A6E03CAFDBDQ46414199-ADE8D250-DB16-47A2-8CF7-3E5B55691281Q46702172-FDEA1C13-E61C-47DB-B0FF-B3D9283507E4Q46737694-2F5195BC-7F32-45E6-B721-AE4FF03F4CDBQ50691937-443D5A4B-5E93-4B3D-BA9F-C9D895D15525
P2860
Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@en
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@nl
type
label
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@en
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@nl
prefLabel
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@en
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@nl
P2093
P1476
Erythrocyte mean corpuscular v ...... thioprine or 6-mercaptopurine.
@en
P2093
Amy L Weaver
Carlton W Thomas
Curtis L Franklin
Dennis C Mays
Gennett M Myhre
James J Lipsky
Philip W Lowry
P304
P356
10.1097/00054725-200307000-00004
P577
2003-07-01T00:00:00Z